美聯新材(300586.SZ)簽署《股權轉讓意向性協議》 擬收購浙江金淳高分子材料80%股權
格隆匯1月26日丨美聯新材(300586.SZ)公佈,公司2021年1月26日與張鵬龍、張詩悦在汕頭市簽署了《關於浙江金淳高分子材料有限公司之股權轉讓意向性協議》,公司擬收購張鵬龍持有的浙江金淳高分子材料有限公司50%股權,擬收購張詩悦持有的浙江金淳高分子材料30%股權。具體轉讓價格以雙方後續簽署的正式的股權轉讓協議為準。本次交易系公司基於進一步實施戰略佈局,更好聚焦核心業務的重要實踐,符合公司總體戰略規劃,有利於促進公司業務專業化與規模化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.